FDA Inspection
Fagron Compounding ServicesFagron Compounding Services – FDA Inspection, Jun 28, 2024
Record Details
This FDA Inspection record concerns Fagron Compounding Services, with an inspection on June 28, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dc2197eb-817a-4651-9624-1e79735fb5b2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1244425
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fagron Compounding Services
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| March 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fagron Compounding Services
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.